
In an interview, Neeta Somaiah, MD, discussed potential areas of exploration in treating gastrointestinal stromal tumors.

In an interview, Neeta Somaiah, MD, discussed potential areas of exploration in treating gastrointestinal stromal tumors.

Although not as essential as in other tumor types, genomic testing is increasingly playing a role in guiding treatment for advanced sarcoma.


Recent trials reveal promising advancements in targeted therapies for chondrosarcomas and tenosynovial giant cell tumors.

Neeta Somaiah, MD, discusses the expanding role of targeted therapies in patients with gastrointestinal stromal tumor and how these treatments are bolstering later lines of therapy.

Neeta Somaiah, MD, discusses new and upcoming targeted therapies for sarcomas at the Inaugural Miami Cancer Institute Precision Medicine Oncology Symposium.







Neeta Somaiah, MD, reviews the case of a 68-year-old man with gastrointestinal stromal tumor.

Neeta Somaiah, MD, discusses the evolution of treatment options for patients with a unique sarcoma.

February 3rd 2026

February 9th 2026

July 16th 2020

July 16th 2020

July 16th 2020

July 16th 2020